Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured ...
Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched weight-loss pill, orforglipron, and other ...
In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...
The US Food and Drug Administration’s lead drug regulator George Tidmarsh resigned two days after being placed on administrative leave over personal conduct concerns, according to the US Department of ...
Ready-to-eat pasta meals have been linked to a multistate outbreak of listeriosis, causing at least six deaths, 25 ...
Some studies suggest that creatine supplements may reduce blood pressure, but the evidence is weak. Learn the benefits and ...
2h
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct.
AI-driven relapse predictions could be a tool in the fight against opioid addiction. Find out how researchers used smartphone ...
UniQure , said on Monday its experimental gene therapy for Huntington's disease does not have adequate clinical data to ...
In 2023, 48.5 million people ages 12 or older in the U.S. contended with a substance use disorder or disorders -- for almost 29 million, it was an alcohol use disorder (AUD) and around 27 million ...
Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback